TRAVERE THERAPEUTICS, INC. (TVTX) Gross margin 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
97.9%FY2025 · since FY2016: 96.6% → 97.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 97.9% | +1.2 pp |
| FY2024 | 96.7% | +4.6 pp |
| FY2023 | 92.1% | -3.8 pp |
| FY2022 | 96.0% | -1.1 pp |
| FY2021 | 97.1% | +0.2 pp |
| FY2020 | 96.9% | -0.1 pp |
| FY2019 | 97.0% | +0.4 pp |
| FY2018 | 96.6% | -1.0 pp |
| FY2017 | 97.7% | +1.1 pp |
| FY2016 | 96.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice